- Parasitology researchers celebrated for early contributions in scientific careers
- In collaboration with scientific publisher Parasites & Vector, Boehringer Ingelheim has sponsored the award since its inception in 2014
- The prize is used to promote career growth in parasitology and to keep the memory of parasitologist Odile Bain alive.
Ingelheim, Germany, July 21, 2021 – To celebrate the outstanding contributions to the field of parasitology at the start of their scientific career, Dr Goylette Chami, University of Oxford, UK, and Dr Barbora Pafčo of the Czech Academy of Sciences and University of Veterinary Sciences of Brno, received the Odile Bain Memorial Prize 2021. Since 2014, the ‘Odile Bain Memorial Prize’ (OBMP) has been awarded annually under the sponsorship of Boehringer Ingelheim Animal Health as well as the scientific editor Parasites and vectors.
“The prize is used to advance young parasitologists as well as to perpetuate the memory of Odile Bain1, a pioneer in the field of parasitology ”, explains Prof. Domenico Otranto, President WAAVP (World Association for the Advancement of Veterinary Parasitology). In a virtual ceremony during the WAAVP Dublin 2021 congress on July 20, he presented the award.
An epidemiological perspective on parasitology – Goylette Chami
Goylette Chami’s research interests relate to improving the treatment of parasitic worms in sub-Saharan Africa. His excellent work has significantly contributed to the study of mass drug administration (MDA) through pioneering network charts for the assessment of MDA and neglected tropical diseases. In addition, Goylette Chami’s studies on the main social determinants of persistent schistosomiasis (an “acute and chronic disease caused by parasitic worms”, according to the World Health Organization2) and hookworms have been particularly valued for their impact on marginalized individuals. “I intend to devote my award to researching how we can link exposure to schistosomes over an individual’s lifetime to disease progression,” says Goylette Chami.
Focus on strongylidae nematodes – Barbora Pafčo
Barbora Pafčo’s work focuses on the study of strongylidae nematodes, recently shedding light on the factors leading to gastritis caused by parasitic nematodes in mountain gorillas. She also studied strongylidae nematodes in cattle in the Czech Republic and the global distribution of nematodes of the genus Necator, with implications for the potential for drug resistance and zoonotic risk. She is interested in the ecology of parasites, the host-parasite relationship and the molecular diversity of pathogens. Barbora Pafčo shares: “Among other things, receiving the Odile Bain Memorial Prize shows me that my contributions are appreciated, which motivates me even more to strive for excellence.
In the footsteps of Odile Bain
The two winners each receive a cash prize. In addition, they can attend the WAAVP Dublin 2021 congress for free to benefit from learning and networking opportunities. The winners also receive a fee waiver for the publication of an article in Parasites & Vectors. Marielle Servonnet, Global Technical Director of Pet Parasiticides Boehringer Ingelheim, adds: “We are delighted to see what Goylette Chami and Barbora Pafčo will do next and are proud to help support their research with this award.
About the World Association for the Advancement of Veterinary Parasitology (WAAVP)
The World Association for the Advancement of Veterinary Parasitology (WAAVP) is a non-profit organization for scientists who study parasites in non-human animals, encompassing helminthology, protozoology, and entomology. After: https://www.waavp.org/
Boehringer Ingelheim Animal Health
The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Around the world, our 9,700 employees are dedicated to creating value through innovation, improving the well-being of both.
Respect for animals, humans and the environment is at the heart of our actions. We develop solutions and provide services to protect animals from disease and pain. We help our customers take care of the health of their animals and protect our communities from diseases that are deadly and life-threatening to society.
Boehringer Ingelheim Animal Health is the second largest animal health company in the world, with net sales of 4.1 billion euros in 2020 and a presence in more than 150 countries. For more information visit: www.boehringer-ingelheim.com/animal-health/overview.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas where unmet medical needs are great. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Approximately 52,000 employees serve more than 130 markets in the three business areas, human pharmacy, animal health and biopharmaceutical contract manufacturing. Learn more about www.boehringer-ingelheim.com